Silver Book Fact

A one percent reduction in lung, colorectal, breast, leukemia, pancreatic, and brain cancer mortality would reduce productivity costs by $814 million per year.

Bradley, C, K Yabroff, B Dahman, E Feuer, A Mariotto, et al. Productivity Costs of Cancer Mortality in the United States: 2000-2020. J Natl Cancer Inst. 2008; 100(24): 1763-70. http://www.ncbi.nlm.nih.gov/pubmed/19066273

Reference

Title
Productivity Costs of Cancer Mortality in the United States: 2000-2020
Publication
J Natl Cancer Inst
Publication Date
2008
Authors
Bradley, C, K Yabroff, B Dahman, E Feuer, A Mariotto, et al.
Volume & Issue
Volume 100, Issue 24
Pages
1763-70
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Every additional dollar spent on newer, less toxic hormonal therapy for breast cancer patients has produced health gains valued at between $27.03 and $36.81.  
  • Investments in cancer care generated $598 billion of additional value for cancer patients diagnosed between 1983 and 1999.  
  • Cancer mortality declined more than 2% in 2003, a continuation of the decline that began in 1990.  
  • Following the current path, the lung cancer incidence rate will increase by 34% between 2003 and 2023. If an alternative path is taken, there will be 18.4% (92,000) fewer lung…  
  • “If you had been diagnosed with chronic myeloid leukemia (CML) in 1999, chances were that you would not be alive today. Just 3 out of 10 patients survived for…